CVS Health Co. (NYSE:CVS) Shares Sold by Borer Denton & Associates Inc.

Borer Denton & Associates Inc. lowered its position in shares of CVS Health Co. (NYSE:CVS) by 30.7% in the third quarter, HoldingsChannel.com reports. The firm owned 49,010 shares of the pharmacy operator’s stock after selling 21,701 shares during the quarter. CVS Health comprises 1.1% of Borer Denton & Associates Inc.’s holdings, making the stock its 27th largest position. Borer Denton & Associates Inc.’s holdings in CVS Health were worth $3,082,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of CVS. MidAtlantic Capital Management Inc. purchased a new position in shares of CVS Health in the 3rd quarter valued at about $25,000. Livelsberger Financial Advisory acquired a new stake in CVS Health during the third quarter worth approximately $31,000. Reston Wealth Management LLC purchased a new stake in shares of CVS Health during the 3rd quarter worth approximately $32,000. First Community Trust NA boosted its holdings in shares of CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after buying an additional 302 shares in the last quarter. Finally, Kathleen S. Wright Associates Inc. acquired a new stake in CVS Health during the 3rd quarter worth $33,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

CVS has been the subject of several research analyst reports. TD Cowen upgraded shares of CVS Health from a “hold” rating to a “buy” rating and upped their price objective for the company from $59.00 to $85.00 in a research note on Friday, October 4th. UBS Group raised their price target on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a research note on Thursday, November 7th. Royal Bank of Canada decreased their price objective on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a report on Friday, November 15th. Barclays cut their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday, November 7th. Finally, Mizuho decreased their price target on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. One analyst has rated the stock with a sell rating, seven have given a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $72.28.

CVS Health Stock Up 1.6 %

CVS opened at $58.01 on Friday. The business has a 50 day simple moving average of $59.21 and a 200-day simple moving average of $58.61. CVS Health Co. has a 12 month low of $52.71 and a 12 month high of $83.25. The stock has a market capitalization of $73.00 billion, a P/E ratio of 14.72, a P/E/G ratio of 0.96 and a beta of 0.55. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping the consensus estimate of $1.08 by $0.01. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business’s revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the firm earned $2.21 EPS. On average, equities analysts anticipate that CVS Health Co. will post 5.43 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.59%. CVS Health’s payout ratio is 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.